{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:00:47Z","timestamp":1758045647309,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.amjsurg.2022.09.060","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T11:01:52Z","timestamp":1666177312000},"page":"304-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4880-2865","authenticated-orcid":false,"given":"Jaclyn A.","family":"Gellings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-5028","authenticated-orcid":false,"given":"Chandler S.","family":"Cortina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7777-6670","authenticated-orcid":false,"given":"Julie M.","family":"Jorns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan K.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiang-Ching","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.amjsurg.2022.09.060_bib1","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24","volume":"30","author":"Allred","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2022.09.060_bib2","first-page":"725","article-title":"Ductal carcinoma in situ","volume":"98","author":"Fu","year":"2018","journal-title":"Surg Clin"},{"key":"10.1016\/j.amjsurg.2022.09.060_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7150\/jca.2.232","article-title":"Biological markers in DCIS and risk of breast recurrence: a systematic review","volume":"2","author":"Lari","year":"2011","journal-title":"J Cancer"},{"issue":"8","key":"10.1016\/j.amjsurg.2022.09.060_bib4","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1158\/1055-9965.EPI-18-1262","article-title":"Incidence of ductal carcinoma in situ in the United States, 2000-2014","volume":"28","author":"Ryser","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.amjsurg.2022.09.060_bib5","first-page":"481","article-title":"Cancer statistics: breast cancer in situ","volume":"65","author":"Ward","year":"2015","journal-title":"CA A Cancer J Clin"},{"issue":"4","key":"10.1016\/j.amjsurg.2022.09.060_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11912-019-0777-3","article-title":"Management of ductal carcinoma in situ (DCIS) of the breast: present approaches and future directions","volume":"21","author":"Solin","year":"2019","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"10.1016\/j.amjsurg.2022.09.060_bib7","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr3462","article-title":"Estrogen receptor negative\/progesterone receptor positive breast cancer is not a reproducible subtype","volume":"15","author":"Hefti","year":"2013","journal-title":"Breast Cancer Res"},{"issue":"9","key":"10.1016\/j.amjsurg.2022.09.060_bib8","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1200\/JCO.2004.99.251","article-title":"Time to stop progesterone receptor testing in breast cancer management","volume":"22","author":"Olivotto","year":"2004","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.amjsurg.2022.09.060_bib9","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.2005.05.167","article-title":"Progesterone receptor testing: not the right time to be buried","volume":"23","author":"Colozza","year":"2005","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.amjsurg.2022.09.060_bib11","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.amjsurg.2022.09.060_bib12","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer [published correction appears in J Clin Oncol. 2010 Jul 20;28(21):3543]","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.amjsurg.2022.09.060_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjsurg.2022.09.060_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.amjsurg.2019.08.004","article-title":"Are we choosing wisely in elderly females with breast cancer?","volume":"218","author":"Calderon","year":"2019","journal-title":"Am J Surg"},{"issue":"9169","key":"10.1016\/j.amjsurg.2022.09.060_bib15","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: national Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.amjsurg.2022.09.060_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM198503143121101","article-title":"Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer","volume":"312","author":"Fisher","year":"1985","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjsurg.2022.09.060_bib17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.amjsurg.2022.09.060_bib19","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1245\/s10434-021-09972-2","article-title":"Ductal carcinoma in situ in young women: increasing rates of mastectomy and variability in endocrine therapy use","volume":"28","author":"Byun","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.amjsurg.2022.09.060_bib18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/PAS.0000000000000674","article-title":"Reflex estrogen receptor (ER) and progesterone receptor (PR) analysis of ductal carcinoma in situ (DCIS) in breast needle core biopsy specimens: an unnecessary exercise that costs the United States $35 million\/y","volume":"40","author":"VandenBussche","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.amjsurg.2022.09.060_bib20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.09.060_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjsurg.2022.09.060_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-med-050715-104920","article-title":"Controversies in the treatment of ductal carcinoma in situ","volume":"68","author":"Barrio","year":"2017","journal-title":"Annu Rev Med"},{"issue":"7","key":"10.1016\/j.amjsurg.2022.09.060_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1158\/1940-6207.CAPR-17-0029","article-title":"Tamoxifen acceptance and adherence among patients with ductal carcinoma in situ (DCIS) treated in a multidisciplinary setting","volume":"10","author":"Karavites","year":"2017","journal-title":"Cancer Prev Res (Phila)."},{"issue":"4","key":"10.1016\/j.amjsurg.2022.09.060_bib24","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1245\/s10434-011-2070-z","article-title":"Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer","volume":"19","author":"Wink","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.09.060_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clbc.2021.07.005","article-title":"Invasive breast cancer treatment patterns in women age 80 and over: a report from the national cancer database","volume":"22","author":"Frebault","year":"2022","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"10.1016\/j.amjsurg.2022.09.060_bib26","doi-asserted-by":"crossref","first-page":"e1289","DOI":"10.1016\/j.clbc.2018.07.004","article-title":"Are providers and patients following hormonal therapy guidelines for patients over the age of 70? The influence of CALGB 9343","volume":"18","author":"Cortina","year":"2018","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.09.060_bib27","first-page":"23","article-title":"Comparison of treatment costs for breast cancer, by tumor stage and type of service","volume":"9","author":"Blumen","year":"2016","journal-title":"Am Health Drug Benefits"},{"issue":"5","key":"10.1016\/j.amjsurg.2022.09.060_bib28","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1245\/s10434-020-09216-9","article-title":"Financial toxicity following surgical treatment for breast cancer: a cross-sectional pilot study","volume":"28","author":"Offodile","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.09.060_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10549-018-4976-7","article-title":"Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty","volume":"173","author":"Resnicow","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.amjsurg.2022.09.060_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.pathol.2019.07.005","article-title":"Ductal carcinoma in situ of breast: update 2019","volume":"51","author":"Badve","year":"2019","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.amjsurg.2022.09.060_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1200\/OP.20.00735","article-title":"Bundled payment Models in Oncology: learning to think in new ways","volume":"17","author":"Kline","year":"2021","journal-title":"JCO Oncol Pract"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961022006304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961022006304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:26:42Z","timestamp":1757701602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961022006304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0002961022006304"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2022.09.060","relation":{},"ISSN":["0002-9610"],"issn-type":[{"type":"print","value":"0002-9610"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2022.09.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}